Genomtec S.A. (WSE:GMT)
Poland · Delayed Price · Currency is PLN 3.630
+0.010 (0.28%)
Sep 4, 2026, 5:00 PM CET
Genomtec Revenue
In the year 2025, Genomtec had annual revenue of 4.03M PLN with 73.80% growth. Genomtec had revenue of 2.31M in the quarter ending December 31, 2025, a decrease of -0.21%.
Revenue
4.03M
Revenue Growth
+73.80%
P/S Ratio
1,822.82
Revenue / Employee
n/a
Employees
32
Market Cap
54.68M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.03M | 1.71M | 73.80% |
| Dec 31, 2024 | 2.32M | 1.18M | 102.53% |
| Dec 31, 2023 | 1.15M | 660.00K | 135.80% |
| Dec 31, 2022 | 486.00K | 269.40K | 124.37% |
| Dec 31, 2021 | 216.60K | 196.26K | 964.60% |
| Dec 31, 2020 | 20.35K | -132.37K | -86.68% |
| Dec 31, 2019 | 152.72K | 141.28K | 1,235.28% |
| Dec 31, 2018 | 11.44K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Synektik Spólka Akcyjna | 932.97M |
| Medicalgorithmics | 34.45M |
| InventionMed | 2.90M |
| Nestmedic | 795.19K |
| Zortrax | 723.51K |
| Adiuvo Investments | 431.00K |
| Medinice | 19.00K |
| Milton Essex Spólka Akcyjna | 425.00 |
Genomtec News
- 3 months ago - Genomtec Quarterly report: Q1 2026 - Filings
- 4 months ago - Genomtec Annual report: Q4 2025 - Filings
- 9 months ago - Genomtec Quarterly report: Q3 2025 - Filings
- 11 months ago - Genomtec Quarterly report: Q2 2025 - Filings